Many metabolic and other pathways dysregulated by TCDD have been identified 11, but the precise mechanisms of TCDD action and in particular the role of AhR downstream genes that mediate the effects of chronic TCDD exposure on liver metabolic diseases, including NASH and liver fibrosis, remains an area of active investigation. This evidence concerns the gene AHR and Hepatic fibrosis.